Using semaglutide as a weight-loss medication has been successful in clinical trials
The effect of semaglutide varies, depending on a variety of individual factors, such as metabolism, lifestyle, adherence to the medication, and medical history
IL-6 also enhances insulin secretion by increasing glucagon-like peptide-1 secretion from intestinal L cells and pancreatic alpha cells, suggesting that IL-6 may mediate muscle-gut-pancreas crosstalk (150)
Supports immune health
A multicenter, randomized, phase 3b trial, done in collaboration with a UNC School of Medicine researcher, found that once-daily oral semaglutide taken at higher doses of 25mg and 50mg improved regulation of blood sugar levels and weight loss compared to the standard 14 mg dose
Individual response to GLP-1 medications varies